2006
DOI: 10.1002/pros.20407
|View full text |Cite
|
Sign up to set email alerts
|

Renin‐angiotensin system is an important factor in hormone refractory prostate cancer

Abstract: The present data suggest that prostatic RAS is overexpressed in HRPC tissue, and expression of its components is influenced by several kinds of hormonal stimulation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
43
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 57 publications
(44 citation statements)
references
References 44 publications
1
43
0
Order By: Relevance
“…Human vascular smooth muscle cells express androgen receptors 31 and would be anticipated to respond to androgen. In addition, incubation of androgen-dependent human prostate cancer cells with DHT increased AT1 receptor mRNA and protein, 32 supporting androgen regulation of human AT1 receptors. However, it is unclear whether human aortic smooth muscle cells expressed along the length of the aorta respond differentially to androgen to increase AT1 receptor expression.…”
Section: Discussionmentioning
confidence: 71%
“…Human vascular smooth muscle cells express androgen receptors 31 and would be anticipated to respond to androgen. In addition, incubation of androgen-dependent human prostate cancer cells with DHT increased AT1 receptor mRNA and protein, 32 supporting androgen regulation of human AT1 receptors. However, it is unclear whether human aortic smooth muscle cells expressed along the length of the aorta respond differentially to androgen to increase AT1 receptor expression.…”
Section: Discussionmentioning
confidence: 71%
“…Thus, there may be a potential beneficial role of AT2R in cancer, and this idea is supported by data that indicate that pheochromocytoma growth is inhibited by AT2R activation (19). With regard to the prostate, there is clear evidence of a tissue-based renin-angiotensin system within this gland and studies to date indicate beneficial actions of blocking AT1R and activating AT2R (15,(20)(21)(22)(23). For example, AT1R inhibitors decrease the growth of some prostate cancer cell lines and delay the development of prostate cancer, whereas AT2R inhibitors are present and have the ability to inhibit epidermal growth factor-induced prostate cancer cell growth in LNCaP and fast-growing androgen-independent PC3 cell lines (24).…”
Section: Introductionmentioning
confidence: 92%
“…The RAS is deregulated in several cancers and can influence several aspects of tumor growth. [1][2][3][4][5] Enzymatic action by the angiotensin converting enzyme (ACE) yields the principal effector peptide of the RAS, Angiotensin II (ANG II). ANG II mediates proliferative, angiogenic, and inflammatory effects through the angiotensin type I receptor (AT1R).…”
Section: Introductionmentioning
confidence: 99%